Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,660 | 4,918 | 4,423 | 8,390 | 6,061 |
| Marketable Securities | 701 | 1,405 | 5,696 | 3,973 | 9,840 |
| TOTAL | $8,459 | $7,057 | $10,803 | $13,461 | $17,201 |
| Non-Current Assets | |||||
| PPE Net | 24 | 28 | 32 | 36 | 40 |
| Other Non-Current Assets | 119 | 138 | 201 | 130 | 180 |
| TOTAL | $143 | $166 | $233 | $166 | $220 |
| Total Assets | $8,602 | $7,223 | $11,036 | $13,627 | $17,420 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,283 | 3,718 | 4,423 | 3,946 | 4,753 |
| TOTAL | $4,323 | $3,777 | $4,502 | $4,040 | $4,884 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,497 | 0 | 0 | 0 | 14 |
| TOTAL | $7,497 | $N/A | $N/A | $N/A | $14 |
| Total Liabilities | $11,820 | $3,777 | $4,502 | $4,040 | $4,898 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,784 | 11,305 | 11,255 | 11,184 | 10,799 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -103,546 | -96,474 | -93,145 | -89,071 | -84,893 |
| Other shareholders' equity | -40 | -36 | 26 | 40 | 48 |
| TOTAL | $-3,217 | $3,446 | $6,534 | $9,587 | $12,522 |
| Total Liabilities And Equity | $8,602 | $7,223 | $11,036 | $13,627 | $17,420 |